✦ LIBER ✦

P.244 Pegylated interferon alpha-2a for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)

✍ Scribed by S.A. Ismail; M.K. Mohamed; H. Mansour; C. Rekacewicz; R.R. Gad; M. El-Houssinie; N.M. Sharaf El-Din; M. El-Daly; S. El-Kafrawy; M. Abdel-Hamid; S. Pol; A. Fontanet; G. Esmat

Book ID: 117770463
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 145 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80424-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

604 Pegylated interfon for treatment of

604 Pegylated interfon for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

559 Combined pegylated interferon α-2a a

559 Combined pegylated interferon α-2a and ribavirin in treatment of chronic hepatitis C in Egypt (ANRS 1211 Trial)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

P.247 Prediction of treatment outcome in

P.247 Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)

✍ G. Esmat; H. ElMakhzangy; S. Males; R.R. Gad; C. Rekacewicz; S.A. Ismail; M. Abd 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

PIN53 Cost-Effectiveness Analysis of Peg

PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

✍ T. Macioch; J. Paweska; M. Niewada; H. Berak; M. Szkultecka-Debek; M. Russel-Szy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

314 Randomized Controlled Trial of Pegyl

314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6

✍ Lam, Khoa D.; Trinh, Huy N.; Do, Son T.; Nguyen, Thuan T.; Garcia, Ruel T.; Nguy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may